ID MARH3_HUMAN Reviewed; 253 AA. AC Q86UD3; A8K264; B9EJE7; DT 15-FEB-2005, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2003, sequence version 1. DT 22-FEB-2023, entry version 156. DE RecName: Full=E3 ubiquitin-protein ligase MARCHF3; DE EC=2.3.2.27; DE AltName: Full=Membrane-associated RING finger protein 3; DE AltName: Full=Membrane-associated RING-CH protein III; DE Short=MARCH-III; DE AltName: Full=RING finger protein 173; DE AltName: Full=RING-type E3 ubiquitin transferase MARCHF3 {ECO:0000305}; GN Name=MARCHF3 {ECO:0000312|HGNC:HGNC:28728}; Synonyms=MARCH3, RNF173; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLN-68. RC TISSUE=Thalamus; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15372022; DOI=10.1038/nature02919; RA Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., RA Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., RA She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S., RA Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M., RA Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M., RA Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T., RA Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., RA Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R., RA Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L., RA Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N., RA Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., RA Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., RA Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.; RT "The DNA sequence and comparative analysis of human chromosome 5."; RL Nature 431:268-274(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP SUBCELLULAR LOCATION. RX PubMed=16428329; DOI=10.1093/jb/mvj012; RA Fukuda H., Nakamura N., Hirose S.; RT "MARCH-III is a novel component of endosomes with properties similar to RT those of MARCH-II."; RL J. Biochem. 139:137-145(2006). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-237 AND SER-243, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). CC -!- FUNCTION: E3 ubiquitin-protein ligase which may be involved in CC endosomal trafficking. E3 ubiquitin ligases accept ubiquitin from an E2 CC ubiquitin-conjugating enzyme in the form of a thioester and then CC directly transfer the ubiquitin to targeted substrates. CC {ECO:0000250|UniProtKB:Q5XIE5}. CC -!- CATALYTIC ACTIVITY: CC Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + CC [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L- CC cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; CC EC=2.3.2.27; CC -!- PATHWAY: Protein modification; protein ubiquitination. CC -!- SUBUNIT: Interacts with MARCHF2 and STX6. {ECO:0000250}. CC -!- INTERACTION: CC Q86UD3; Q9BQE5: APOL2; NbExp=3; IntAct=EBI-2341065, EBI-4290634; CC Q86UD3; Q969F0: FATE1; NbExp=3; IntAct=EBI-2341065, EBI-743099; CC Q86UD3; P61086: UBE2K; NbExp=3; IntAct=EBI-2341065, EBI-473850; CC -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane CC {ECO:0000269|PubMed:16428329}; Multi-pass membrane protein CC {ECO:0000269|PubMed:16428329}. Early endosome membrane CC {ECO:0000269|PubMed:16428329}; Multi-pass membrane protein CC {ECO:0000269|PubMed:16428329}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q86UD3-1; Sequence=Displayed; CC Name=2; CC IsoId=Q86UD3-2; Sequence=VSP_055451, VSP_055452; CC -!- DOMAIN: The RING-CH-type zinc finger domain is required for E3 ligase CC activity. {ECO:0000255|PROSITE-ProRule:PRU00623}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK290129; BAF82818.1; -; mRNA. DR EMBL; AC004507; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC005221; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC093532; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC137794; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471062; EAW62412.1; -; Genomic_DNA. DR EMBL; CH471062; EAW62413.1; -; Genomic_DNA. DR EMBL; BC047569; AAH47569.1; -; mRNA. DR EMBL; BC146948; AAI46949.1; -; mRNA. DR EMBL; BC146964; AAI46965.1; -; mRNA. DR CCDS; CCDS4141.1; -. [Q86UD3-1] DR RefSeq; NP_848545.1; NM_178450.4. [Q86UD3-1] DR AlphaFoldDB; Q86UD3; -. DR SMR; Q86UD3; -. DR BioGRID; 125416; 42. DR IntAct; Q86UD3; 11. DR MINT; Q86UD3; -. DR STRING; 9606.ENSP00000309141; -. DR TCDB; 8.A.159.1.9; the march ubiquitin ligase (march) family. DR iPTMnet; Q86UD3; -. DR PhosphoSitePlus; Q86UD3; -. DR BioMuta; MARCH3; -. DR DMDM; 59798460; -. DR MassIVE; Q86UD3; -. DR PaxDb; Q86UD3; -. DR PeptideAtlas; Q86UD3; -. DR Antibodypedia; 25757; 171 antibodies from 27 providers. DR DNASU; 115123; -. DR Ensembl; ENST00000308660.6; ENSP00000309141.5; ENSG00000173926.6. [Q86UD3-1] DR Ensembl; ENST00000515241.1; ENSP00000421979.1; ENSG00000173926.6. [Q86UD3-2] DR GeneID; 115123; -. DR KEGG; hsa:115123; -. DR MANE-Select; ENST00000308660.6; ENSP00000309141.5; NM_178450.5; NP_848545.1. DR UCSC; uc003kuf.4; human. [Q86UD3-1] DR AGR; HGNC:28728; -. DR CTD; 115123; -. DR DisGeNET; 115123; -. DR GeneCards; MARCHF3; -. DR HGNC; HGNC:28728; MARCHF3. DR HPA; ENSG00000173926; Low tissue specificity. DR MIM; 613333; gene. DR neXtProt; NX_Q86UD3; -. DR OpenTargets; ENSG00000173926; -. DR VEuPathDB; HostDB:ENSG00000173926; -. DR eggNOG; KOG1609; Eukaryota. DR GeneTree; ENSGT00940000159206; -. DR HOGENOM; CLU_096532_0_0_1; -. DR InParanoid; Q86UD3; -. DR OMA; TYCELCH; -. DR OrthoDB; 1342875at2759; -. DR PhylomeDB; Q86UD3; -. DR TreeFam; TF319557; -. DR PathwayCommons; Q86UD3; -. DR SignaLink; Q86UD3; -. DR SIGNOR; Q86UD3; -. DR UniPathway; UPA00143; -. DR BioGRID-ORCS; 115123; 30 hits in 1108 CRISPR screens. DR ChiTaRS; MARCH3; human. DR GenomeRNAi; 115123; -. DR Pharos; Q86UD3; Tbio. DR PRO; PR:Q86UD3; -. DR Proteomes; UP000005640; Chromosome 5. DR RNAct; Q86UD3; protein. DR Bgee; ENSG00000173926; Expressed in pancreatic ductal cell and 145 other tissues. DR Genevisible; Q86UD3; HS. DR GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005768; C:endosome; IDA:UniProtKB. DR GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA. DR GO; GO:0005764; C:lysosome; IDA:UniProtKB. DR GO; GO:0004842; F:ubiquitin-protein transferase activity; IBA:GO_Central. DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro. DR GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW. DR GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central. DR CDD; cd16699; RING_CH-C4HC3_MARCH2_like; 1. DR Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1. DR InterPro; IPR001841; Znf_RING. DR InterPro; IPR011016; Znf_RING-CH. DR InterPro; IPR013083; Znf_RING/FYVE/PHD. DR PANTHER; PTHR46065; E3 UBIQUITIN-PROTEIN LIGASE MARCH 2/3 FAMILY MEMBER; 1. DR PANTHER; PTHR46065:SF2; E3 UBIQUITIN-PROTEIN LIGASE MARCHF3; 1. DR Pfam; PF12906; RINGv; 1. DR SMART; SM00744; RINGv; 1. DR SUPFAM; SSF57850; RING/U-box; 1. DR PROSITE; PS51292; ZF_RING_CH; 1. PE 1: Evidence at protein level; KW Alternative splicing; Cytoplasmic vesicle; Endocytosis; Endosome; Membrane; KW Metal-binding; Phosphoprotein; Reference proteome; Transferase; KW Transmembrane; Transmembrane helix; Ubl conjugation pathway; Zinc; KW Zinc-finger. FT CHAIN 1..253 FT /note="E3 ubiquitin-protein ligase MARCHF3" FT /id="PRO_0000055927" FT TRANSMEM 145..165 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 182..202 FT /note="Helical" FT /evidence="ECO:0000255" FT ZN_FING 63..123 FT /note="RING-CH-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00623" FT BINDING 71 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00623" FT BINDING 74 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00623" FT BINDING 87 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00623" FT BINDING 89 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00623" FT BINDING 97 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00623" FT BINDING 100 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00623" FT BINDING 113 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00623" FT BINDING 116 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00623" FT MOD_RES 237 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 243 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT VAR_SEQ 132..138 FT /note="WLRNPGP -> VSKWGTS (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_055451" FT VAR_SEQ 139..253 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_055452" FT VARIANT 68 FT /note="R -> Q (in dbSNP:rs34821177)" FT /evidence="ECO:0000269|PubMed:14702039" FT /id="VAR_053639" SQ SEQUENCE 253 AA; 28504 MW; 6E090675CEBC8A88 CRC64; MTTSRCSHLP EVLPDCTSSA APVVKTVEDC GSLVNGQPQY VMQVSAKDGQ LLSTVVRTLA TQSPFNDRPM CRICHEGSSQ EDLLSPCECT GTLGTIHRSC LEHWLSSSNT SYCELCHFRF AVERKPRPLV EWLRNPGPQH EKRTLFGDMV CFLFITPLAT ISGWLCLRGA VDHLHFSSRL EAVGLIALTV ALFTIYLFWT LVSFRYHCRL YNEWRRTNQR VILLIPKSVN VPSNQPSLLG LHSVKRNSKE TVV //